Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Squamous Non-small-cell Lung Cancer × Gemcitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 3 Pancreatic Neoplasms 2 Lymphoma, T-Cell, Peripheral 2 Squamous Non-small-cell Lung Cancer 1 Oligospermia 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Fibrosis 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Biliary Tract Neoplasms 1 Adenocarcinoma Pancreas 1 Adenocarcinoma 1

Interventions

Gemcitabine 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02996214 2020-02-13

LIPUSU

Nanjing Luye Sike Pharmaceutical Co., Ltd.

Phase 4 Unknown

Squamous Non-small-cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡